Applied Clinical Trials
June 01, 2010
Issue PDF
0
0
GLOBAL TRIALS : New Survey Baselines Global Sites Keys to Success in China Budgeting for Global Trials European Ethics Committees CRO/SPONSOR : Think About the Drug Label First LABS : 3-Prong Model for CV Safety Immune Response Screens a Necessity eCLINICAL : ePRO?s Tipping Point Also in this issue : FDA?s New Risk Approach to Site Inspections, EMA Speaks to Stem Cell Research, Mother Lode of Latent Research Data
June 01, 2010
A Closing Thought
0
0
The 12-year data exclusivity period has significant implications in delaying the launch of biosimilars.
June 01, 2010
Business News
0
0
Industry news focusing on the people and organizations who work in the clinical trials profession.
June 01, 2010
A Closing Thought
0
0
There is still an endemic inefficiency in health care and clinical trial record connectivity.
June 01, 2010
Feature Article
0
0
Overcoming method validation challenges for trial populations during biologic drug development.
June 01, 2010
Feature Article
0
0
The financial advantages of using ePRO over paper-based diaries when conducting clinical trials.
June 01, 2010
Feature Article
0
0
New survey from Tufts CSDD and Applied Clinical Trials provides an inside look at global sites.
June 01, 2010
View from Brussels
0
0
New guidelines are being developed in Europe to address questions regarding stem-cell medicines.
June 01, 2010
Global News
0
0
The newest report from the European Forum for Good Clinical Practice identifies the widely diverse ethical approval system across Europe.
June 01, 2010
Feature Article
0
0
Step-by-step process for budgeting global trials that uses a Currency Risk Management method.
June 01, 2010
Phase News
0
0
Updates on the respiratory therapeutic market.
June 01, 2010
Feature Article
0
0
Guidance for auditing quality systems of independent ethics committees throughout Europe.
June 01, 2010
Feature Article
0
0
Employing a three-component risk exclusion model in the assessment of investigational drugs.
June 01, 2010
0
0
On several occasions each year, Industry Standard Research (ISR) has the opportunity to speak with sponsor companies about their outsourcing practices.
June 01, 2010
Feature Article
0
0
Even before trials start, compiling a "target label" can add value by helping steer product development.
June 01, 2010
View from Washington
0
0
FDA eyes risk approaches to site inspections to use resources more efficiently.
June 01, 2010
Technology Viewpoint
0
0
What it can mean for the future of health care studies and how it can benefit clinical trials' patients.
June 01, 2010
Feature Article
0
0
Cultural, technological, and practical issues that need to be addressed to increase success.